SPDL1 and non-small cell lung carcinoma: <h4>Objective</h4>The objective of this study was to explore whether soluble programmed death ligand 1 (sPD-L1) is a potential prognostic biomarker in patients with non-small cell lung cancer (NSCLC).<h4>Methods</h4>A comprehensive search of electronic databases was carried out.